Publications by authors named "E V Zbyshevskaya"
Article Synopsis
- The study aims to evaluate the variability in measurements of atherosclerotic plaque (ASP) area and height in carotid arteries, proposing these as potential indicators for assessing the effectiveness of secondary prevention after acute coronary syndrome (ACS).
- Analysis was conducted on patients with confirmed ACS and recorded ASP, revealing that variability in measurements between different studies was notably higher than that within the same study, indicating inconsistencies in data collection or methodology.
- Although some changes in ASP parameters were observed over a six-month follow-up, the differences were not statistically significant, highlighting the need for improved protocols and training for the specialists involved in these evaluations.
Coronary revascularization is one of the most studied treatment modalities in cardiology; however, there is no consensus among experts about its indications in patients with stable coronary artery disease (SCAD). Contemporary data regarding the role of revascularization in SCAD are in clear conflict with the current European guidelines. This article discusses the main statements of the most significant American and European Guidelines on myocardial revascularization of the last decade and also analyzes the appropriateness of revascularization to improve the prognosis and symptoms in SCAD in the light of new research data, primarily the ISCHEMIA study (NCT01471522) and the ACC/AHA 2021 Revascularization Guidelines based on them.
View Article and Find Full Text PDFUnlabelled: Indications for coronary revascularization in patients with stable coronary heart disease (CHD), presented in the current international guidelines are largely based on the clinical trials conducted sometimes more than 30 years ago. ISCHEMIA is the major multicenter international randomized trial intended to answer the question about the optimal treatment strategy in stable coronary artery disease at the present time.
Purpose: To analyze the most important baseline characteristics of patients enrolled in the ISCHEMIA study in one Russian site.